Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 4,901 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Strategy & Legal Officer gave up 4,699 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 4,701 shares (to pay taxes)
  4. 4 Grant or award Director acquired 7,768 shares (grant or award)
  5. 4 Grant or award Director acquired 7,768 shares (grant or award)
  6. 4 Grant or award Director acquired 7,768 shares (grant or award)
  7. 4 Grant or award Director acquired 7,768 shares (grant or award)
  8. 4 Grant or award Director acquired 7,768 shares (grant or award)
  9. 4 Grant or award Director acquired 7,768 shares (grant or award)
  10. 4 Grant or award Director acquired 7,768 shares (grant or award)
  11. 4 Grant or award Director acquired 7,768 shares (grant or award)
  12. 4 Grant or award Director acquired 7,768 shares (grant or award)
  13. 4 Planned sale Director sold 20,602 shares at $7.91 ($163,046)
  14. 4 Shares withheld for taxes Chief Legal Officer gave up 4,700 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 5,263 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,452 shares (to pay taxes)
  17. 4 Exercise or conversion Director acquired 30,752 shares (option exercise)
  18. 3 Insider Initial Statement of Ownership
  19. 4/A Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 13,891 shares (to pay taxes)

Page 3 of 22 · 435 filings